Prognostic value of chronic obstructive pulmonary disease in 2994 cases of lung cancer

被引:63
作者
López-Encuentra, A [1 ]
Astudillo, J [1 ]
Cerezal, J [1 ]
Gonzalez-Aragoneses, F [1 ]
Novoa, N [1 ]
Sánchez-Palencia, A [1 ]
机构
[1] Hosp Univ 12 Octubre, Pneumol Serv, Madrid 28041, Spain
关键词
lung cancer; chronic obstructive pulmonary disease; prognosis; conditional survival analysis; comorbidity; surgery;
D O I
10.1016/j.ejcts.2004.09.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Given the frequent association between chronic obstructive pulmonary disease (COPD) and lung cancer (I-C), the objective of this paper is to analyse the prognosis of this comorbidity. Methods: Multicenter prospective study compiling 2994 consecutive cases of surgically treated LC (1993-1997), the population with non-small cell lung cancer and complete resection was selected for the prognostic study of COPD. COPD is defined when the FEV1/FVC is < 0.7 (n = 1370; 46%). Overall and conditional survivals (survival likelihood when alive at 2, 3 or 5 years after treatment) as welt as the degree of severity (FEV1% percentiles) were calculated to establish prognosis. Results: Although the overall survival is similar whether or not COPD is present (Log-rank: 0.34), the conditional survival analysis is different in every stage at 60 months (Log-rank: 0.02) and different in stage pl at 24-36 months (Log-rank: 0.04). In LC (stage pl) with COPD, the presence of a worst pulmonary function (last FEV1% percentile vs first FEV1% percentile) is a bad prognostic factor (Log-rank: 0.002). Conclusions: The analysis of conditional survival at 24 months shows that COPD can be considered as a prognostic factor and that there is a clear relationship between the severity of the condition (FEV1%) and survival. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 25 条
  • [1] Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer
    Battafarano, RJ
    Piccirillo, JF
    Meyers, BF
    Hsu, HS
    Guthrie, TJ
    Cooper, JD
    Patterson, GA
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 123 (02) : 280 - 287
  • [2] Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer
    Birim, Ö
    Maat, APWM
    Kappetein, AP
    van Meerbeeck, JP
    Damhuis, RAM
    Bogers, AMC
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 23 (01) : 30 - 34
  • [3] Prognostic factors in non-small cell lung cancer - A decade of progress
    Brundage, MD
    Davies, D
    Mackillop, WJ
    [J]. CHEST, 2002, 122 (03) : 1037 - 1057
  • [4] Population impact of different definitions of airway obstruction
    Celli, BR
    Halbert, RJ
    Isonaka, S
    Schau, B
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (02) : 268 - 273
  • [5] The "Will!Rogers" phenomenon.: Stage migration in bronchogenic carcinoma after applying certainty criteria
    Encuentra, AL
    de la Cámara, AG
    de Ugarte, AV
    Mañes, N
    Llobregat, N
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2002, 38 (04): : 166 - 171
  • [6] Encuentra AL, 1998, LUNG CANCER, V20, P161
  • [7] FEINSTEIN AR, 1990, MEDICINE, V69, P1
  • [8] RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER
    HOLMES, CE
    RUCKDESCHEL, JC
    JOHNSTON, M
    THOMAS, PA
    DESLAURIERS, J
    GROVER, FL
    HILL, LD
    FELD, R
    GINSBERG, RJ
    MOUNTAIN, CF
    DZUIBAN, S
    KIELY, M
    MCKNEALLY, MF
    MOORES, DWO
    RAMNES, C
    WAGNER, H
    BUNN, P
    CHU, H
    DIENHART, D
    HAZUKA, M
    KINZIE, J
    SORENSEN, J
    VANCE, V
    BRAUN, T
    HOPEMAN, A
    KANE, M
    RUSS, P
    WHITMAN, GJR
    FALL, SM
    HANSEN, DP
    HENDERSON, RH
    MONCRIEF, CL
    PAULING, F
    SIMS, J
    TELL, D
    WISELYCARR, S
    ABERNATHY, CM
    CLARK, DA
    MCCROSKEY, B
    MOORE, G
    MOORE, F
    MYERS, A
    WHITE, M
    BROOKS, RJ
    BULL, M
    JOHNSON, FB
    NEIMYR, M
    PAQUETTE, FR
    SACCOMANNO, G
    LAD, T
    [J]. ANNALS OF THORACIC SURGERY, 1995, 60 (03) : 615 - 622
  • [9] Development of a comorbidity index using physician claims data
    Klabunde, CN
    Potosky, AL
    Legler, JM
    Warren, JL
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (12) : 1258 - 1267
  • [10] Comorbidity in operable lung cancer -: A multicenter descriptive study on 2992 patients
    López-Encuentra, A
    [J]. LUNG CANCER, 2002, 35 (03) : 263 - 269